share

4-Oxo-4-(3-Oxo-3,4-Dihydro-2H-Quinoxalin-1-Yl)-Butyric Acid CAS NO 462068-46-8


Unit Price:

CAS No.:462068-46-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4-Oxo-4-(3-Oxo-3,4-Dihydro-2H-Quinoxalin-1-Yl)-Butyric Acid is a high-purity, specialized organic compound that serves as a critical building block in advanced chemical synthesis. This compound is valued for its unique quinoxaline-derived structure, which imparts specific reactivity and functionality essential for creating complex molecular architectures. It is primarily sought after by research institutions and industrial R&D departments in the pharmaceutical and agrochemical sectors for the development of novel active ingredients and fine chemicals.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or possessing antimicrobial properties.
  • Agrochemical Research: Used in the development of new herbicides, fungicides, or insecticides, leveraging the bioactive quinoxaline core.
  • Organic Synthesis Building Block: Employed in academic and industrial laboratories for constructing complex heterocyclic compounds and conducting structure-activity relationship (SAR) studies.
  • Material Science Precursor: Potential use in the synthesis of organic semiconductors, dyes, or ligands for catalytic systems due to its conjugated system.
  • Biochemical Probe Development: Serves as a scaffold for creating fluorescent tags or enzyme inhibitors used in biochemical assays and diagnostic research.

Basic Information

Product Name 4-Oxo-4-(3-Oxo-3,4-Dihydro-2H-Quinoxalin-1-Yl)-Butyric Acid
CAS No. 462068-46-8
Molecular Formula C12H10N2O4
Molecular Weight 246.22 g/mol
Synonyms 1-(3-Carboxypropionyl)-3,4-dihydro-2(1H)-quinoxalinone; 4-(3-Oxo-3,4-dihydro-2H-quinoxalin-1-yl)-4-oxobutanoic acid; 1-(3-Carboxypropionyl)-1,2,3,4-tetrahydroquinoxalin-2-one; Butanoic acid, 4-oxo-4-(3-oxo-3,4-dihydro-2H-quinoxalin-1-yl)-; Quinoxaline-1(2H)-butanoic acid, 3,4-dihydro-3-oxo-γ-oxo-
EINECS Contact for details

Quality Control

Our production of 4-Oxo-4-(3-Oxo-3,4-Dihydro-2H-Quinoxalin-1-Yl)-Butyric Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot is fully characterized and tested against rigorous in-house specifications, which typically include identity confirmation by spectroscopic methods (IR, NMR), purity assessment by HPLC, and control of key impurities. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed when not in use to minimize exposure to atmospheric humidity.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Single Unknown Impurity (HPLC) ≤ 0.5%
Total Impurities (HPLC) ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.